Institute of Physiology and Zürich Center for Integrative Human Physiology, University of Zürich, Zürich, Switzerland.
Compr Physiol. 2011 Oct;1(4):1759-94. doi: 10.1002/cphy.c100075.
The hormone erythropoietin (Epo) is the main humoral regulator of erythropoiesis. It binds to specific receptors belonging to the cytokine receptor superfamily. Epo stimulates proliferation and differentiation of erythroid precursor cells, but may also bind to and exert some additional effects in nonhemopoietic tissues. It is mainly produced in the kidneys and to minor extents also in the liver and in the brain. The plasma concentration of erthyropoietin is inversely related to the oxygen content of the blood. The secretion of Epo into the circulation and hence its plasma concentrations are mainly determined by the transcription rate of the Epo gene, which itself is essentially under control of the cellular oxygen concentration. Sinks of the oxygen concentrations increase the activity of the hypoxia-inducible transcription factor (HIF), which in turn triggers Epo gene transcription. Disorders of kidney function lead to inappropriate Epo production, what may result in anemia or polycythemia.
促红细胞生成素(Epo)是红细胞生成的主要体液调节剂。它与细胞因子受体超家族的特定受体结合。Epo 刺激红系前体细胞的增殖和分化,但也可能与非造血组织结合并发挥一些额外的作用。它主要由肾脏产生,在肝脏和大脑中也有少量产生。促红细胞生成素的血浆浓度与血液中的氧含量成反比。Epo 向血液循环中的分泌,因此其血浆浓度主要取决于 Epo 基因的转录率,而 Epo 基因本身主要受细胞内氧浓度的控制。氧浓度的消耗增加了缺氧诱导转录因子(HIF)的活性,而 HIF 又反过来触发 Epo 基因的转录。肾功能障碍会导致 Epo 产生不当,从而导致贫血或红细胞增多症。